SCHEMBL4596522

SCHEMBL4596522

[CH2]C1Cc2ccc(Cl)c(-c3ccccc3C)c2O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
AQP1 P29972 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
MAOB P27338 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
BRD4 O60885 1/20 0.31
CREBBP Q92793 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596281 0.87 GABRA1 (0.34) PTGS1PTGS2AQP1HTR2AHTR2C
SCHEMBL4596523 0.84 HTR1A (0.43) PTGS1PTGS2AQP1NPC1RAB9A
SCHEMBL4596712 0.83 ALDH1A1 (0.32) AQP1HTR2AHTR2CALDH1A1MAPK1
SCHEMBL4236002 0.81 AQP1 (0.44) PTGS1PTGS2AQP1HTR2AHTR2C
SCHEMBL4231158 0.81 AQP1 (0.40) PTGS1PTGS2AQP1HTR2AHTR2C
SCHEMBL4226320 0.79 AQP1 (0.58) PTGS1PTGS2AQP1HTR2AHTR2C
SCHEMBL4226325 0.79 AQP1 (0.39) PTGS1PTGS2AQP1HTR2CALDH1A1
SCHEMBL6047939 0.78 HTR2A (0.40) HTR2AHTR2CALDH1A1MAPK1NPC1
SCHEMBL6047915 0.75 ALDH1A1 (0.35) AQP1HTR2AHTR2CALDH1A1NPC1
SCHEMBL4596979 0.75 AQP1 (0.40) AQP1HTR2AHTR2CHTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007509174-A 2007-04-12 JP claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP claimed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO claimed
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP disclosed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO disclosed